Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Laskou, Styliani K
NCT05294393: Ropivacaine Plus Magnesium Sulphate Infiltration	Completed	4	68	Europe	Placebo Comparator: N/S 0.9%, Ropivacaine 10%, Ropivacaine 10% plus magnesium sulphate 10mg/kg	Aristotle University Of Thessaloniki	Thyroid Diseases, Parathyroid Diseases, Postoperative Pain, Anesthesia, Local	01/24	01/24
NCT06176976: Preoperative Administration of Lugols Solution in Toxic Thyroid Diseases (TD): A Prospective Study	Active, not recruiting	N/A	50	Europe	Lugol's iodine solution 5%	Aristotle University Of Thessaloniki	Toxic; Thyroid	01/25	06/25

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Laskou, Styliani K
NCT05294393: Ropivacaine Plus Magnesium Sulphate Infiltration	Completed	4	68	Europe	Placebo Comparator: N/S 0.9%, Ropivacaine 10%, Ropivacaine 10% plus magnesium sulphate 10mg/kg	Aristotle University Of Thessaloniki	Thyroid Diseases, Parathyroid Diseases, Postoperative Pain, Anesthesia, Local	01/24	01/24
NCT06176976: Preoperative Administration of Lugols Solution in Toxic Thyroid Diseases (TD): A Prospective Study	Active, not recruiting	N/A	50	Europe	Lugol's iodine solution 5%	Aristotle University Of Thessaloniki	Toxic; Thyroid	01/25	06/25